Market closedNon-fractional

aTyr Pharma/ATYR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About aTyr Pharma

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Ticker

ATYR

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

San Diego, United States

Employees

58

aTyr Pharma Metrics

BasicAdvanced
$104M
Market cap
-
P/E ratio
-$0.90
EPS
1.19
Beta
-
Dividend rate
$104M
1.19
6.065
5.443
15.413
16.76
-29.37%
-55.61%
153.191
1.22
1.22
-1.553
-94.34%
-36.49%
-37.34%
-26.66%

What the Analysts think about aTyr Pharma

Analyst Ratings

Majority rating from 5 analysts.
Buy

aTyr Pharma Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-7,700.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$200K
∞%
Net income
-$15M
4.76%
Profit margin
-7,700.00%
-∞%

aTyr Pharma Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 2.54%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.22
-$0.20
-$0.25
-$0.23
-
Expected
-$0.28
-$0.23
-$0.24
-$0.24
-$0.24
Surprise
-21.03%
-11.50%
5.04%
-2.54%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for aTyr Pharma stock?

aTyr Pharma (ATYR) has a market cap of $104M as of July 06, 2024.

What is the P/E ratio for aTyr Pharma stock?

The price to earnings (P/E) ratio for aTyr Pharma (ATYR) stock is 0 as of July 06, 2024.

Does aTyr Pharma stock pay dividends?

No, aTyr Pharma (ATYR) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next aTyr Pharma dividend payment date?

aTyr Pharma (ATYR) stock does not pay dividends to its shareholders.

What is the beta indicator for aTyr Pharma?

aTyr Pharma (ATYR) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell aTyr Pharma stock

Buy or sell aTyr Pharma stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing